TY  - GEN
AU  - Wynne,Christopher
AU  - Altendorfer,Mario
AU  - Sonderegger,Ivo
AU  - Gheyle,Lien
AU  - Ellis-Pegler,Rod
AU  - Buschke,Susanne
AU  - Lang,Benjamin
AU  - Assudani,Deepak
AU  - Athalye,Sandeep
AU  - Czeloth,Niklas
TI  - Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE®-PK) in healthy subjects
SN  - 1744-7658
PY  - 2017///0310
KW  - Adalimumab
KW  - administration & dosage
KW  - Adult
KW  - Antirheumatic Agents
KW  - Area Under Curve
KW  - Biosimilar Pharmaceuticals
KW  - Double-Blind Method
KW  - Humans
KW  - Male
KW  - Therapeutic Equivalency
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1080/13543784.2016.1255724
ER  -